ArticleiScience2026
AI enhancing differential diagnosis of acute chronic obstructive pulmonary disease and acute heart failure.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Differentiating acute exacerbation of chronic obstructive pulmonary disease (AECOPD) from acute heart failure (AHF) is clinically challenging due to overlapping symptoms, especially in resource-limited settings lacking radiological/ultrasonographic tools. This study developed an eXtreme Gradient Boosting (XGBoost) model for differential diagnosis using Database: Medical Information Mart for Intensive Care (MIMIC) and two Chinese hospital cohorts, comparing it with a guideline-based model and applying Shapley Additive Explanations (SHAP) analysis to identify key biomarkers. The XGBoost model showed high discriminatory performance (area under the curve [AUC]: 0.94-0.98 across development/validation, outperforming the guideline-based model's AUC of 0.53) with consistent accuracy across age/sex subgroups. Key biomarkers included NT-proBNP and total bilirubin. This robust model enables rapid, accurate differential diagnosis in resource-constrained emergency settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.